Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

ADAM TETREAU

UEI: J66EAGCLE8Y3

ADAM TETREAU is a federal contractor, registered under UEI J66EAGCLE8Y3. It has been awarded $3,896 in federal contracts. Primary work spans Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

J66EAGCLE8Y3

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

1

All time

Active

0

Currently performing

Completed

1

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with ADAM TETREAU

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ADAM TETREAU

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in ADAM TETREAU's top NAICS codes and agencies

NAICS: 541715
New
Federal
NextSTEP-3 Appendix B: Moon Base Demonstrations
Solicitation # M2M-MSFC-0001
The Next Space Technologies for Exploration Partnerships-3 (NextSTEP-3), Appendix B: Moon Base Demonstrations, is a solicitation issued by the NASA Marshall Space Flight Center to advance lunar mission capabilities. The program focuses on bridging the gap between technology development and mission operations by targeting concepts at Technology Readiness Level (TRL) 6 and beyond. Key technical areas include infrastructure, transportation, mobility, habitation, autonomy, robotics, and mission science. The contract is structured as an Indefinite-Delivery, Indefinite-Quantity (IDIQ) vehicle utilizing Firm-Fixed-Price (FFP) task orders, with a performance period spanning from October 27, 2026, to October 26, 2028. NASA utilizes a dual-path call structure consisting of Directed-Topic Calls for specific mission needs—such as Moon Base Data Gaps and Surface Mating Systems—and Open-Topic Calls for broader industry innovation. The selection process is a two-step sequence starting with a white paper submission, followed by a full proposal for invited parties. Awards are determined via a best-value tradeoff process, where intrinsic merit and management approach are weighted more heavily than price. All contractors must adhere to strict NASA technical standards, cybersecurity requirements, and a prohibition on funding activities with Chinese-owned companies.
NASA Marshall Space Flight Center

POSTED

about 19 hours ago

DEADLINE

in about 2 months
View Details
NAICS: 541715
New
Federal
16th Air Force Commercial Solutions Opening
Solicitation # FA7037-23-S-C0001
The 16th Air Force is utilizing a Commercial Solutions Opening (CSO) under 10 USC 3458 and DFARS 212.70 to acquire innovative commercial items, technologies, and services. This overarching umbrella solicitation, numbered FA7037-23-S-C0001, allows the Air Force to issue various Calls to address capability gaps and technological advancements. Key areas of interest include Electromagnetic Warfare, Information Operations, Electromagnetic Digital Communications, and Multi-Domain Innovation. All acquisitions under this framework are treated as commercial items, and awards may be issued as traditional contracts or Other Transaction Agreements. The procurement process generally follows a two-step evaluation based on peer or scientific review. In Step I, offerors submit a Quad Chart and a White Paper to demonstrate technical qualification and merit. If selected, the government invites the offeror to submit a Step II Technical Proposal. While many previous calls for projects such as CFD Modeling, WAPS Scheduling, and AI-Enabled Security Operations have closed, Call 0013 for Innovative Electromagnetic Spectrum Operations Signature Management Support remains open for submissions through November 23, 2026. Offerors must be registered in SAM.gov with a Unique Entity Identifier and CAGE code, and must adhere to specific cybersecurity and classification standards depending on the call requirements.
FA7037 Amic Det 2 Jbsa

POSTED

about 19 hours ago

DEADLINE

in 11 months
View Details
NAICS: 541715
New
Federal
Research, Development, Test & Evaluation (RDT&E) Support for the Center for Corrosion Science and Engineering (CCSE)
Solicitation # N0017326RGF02
The Naval Research Laboratory is soliciting proposals for a Cost-Plus-Fixed-Fee Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract to provide Research, Development, Test and Evaluation (RDT&E) support for the Center for Corrosion Science and Engineering (CCSE). This small business set-aside under NAICS 541715 has a five-year ordering period from February 28, 2027, to February 27, 2032, with a revised maximum total value of 110 million dollars. The scope of work encompasses multi-disciplinary scientific and engineering support in four primary areas: corrosion science and engineering, material science and environmental compatibility, marine coatings science and technology, and technology transfer, field demonstrations, and engineering support. The contract includes an initial Task Order 1 focused on warfighting platform readiness, requiring a total of 30,720 annual hours across 17 labor categories. The government will award the contract to a single responsible offeror based on best value using a tradeoff process. Evaluation factors include technical understanding and approach, staffing and key personnel qualifications, past performance, and cost/price. Key personnel, including the Program Manager IV and IT Specialist IV, must possess active security clearances as specified in the DD Form 254. Performance will primarily take place at the Naval Research Laboratory in Washington, D.C., and requires strict adherence to security protocols, including Top Secret facility clearance and compliance with NISPOM for classified shipments. Proposals must be submitted in five volumes by November 20, 2026, including a native Excel cost workbook and searchable PDF narratives.
Naval Research Laboratory

POSTED

about 19 hours ago

DEADLINE

in 7 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award to develop a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This medical countermeasure must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent systemic infections in combat scenarios. The project aims to advance the technology from a preferred starting point of Technology Readiness Level 5 to TRL 8, requiring the successful execution of preclinical testing, human clinical trials, and the achievement of FDA approval or clearance within the period of performance. The effort will be awarded under prototype Other Transaction Authority 10 U.S.C. 4022, with a preferred Firm Fixed Price structure, although Cost Plus Fixed Fee is acceptable. The estimated period of performance is 48 months, with specific objectives focused on prototype demonstration and regulatory submission. Proposals must be submitted in three distinct volumes covering technical, management, and administrative and cost details by November 20, 2026. Evaluation will be based on technical and management capability, cost, and demonstrated ability to perform, with a specific requirement for statutory eligibility under 10 USC 4022(d)(1) or a one-third cost share.
Defense Health Agency

POSTED

about 19 hours ago

DEADLINE

in 7 days
View Details
NAICS: 541715
New
Federal
Protein Palace
Solicitation # DARPA-PA-27-02
The Protein Palace program, solicitation DARPA-PA-27-02, is an Other Transaction agreement managed by the Defense Advanced Research Projects Agency. The program seeks to develop a universal, generalizable protein purification platform capable of rapidly isolating virtually any protein from complex feedstocks with high specificity, purity, and yield. The objective is to move beyond evolutionary improvements and instead utilize dynamic chemical and physical approaches to probe physicochemical variations, thereby breaking the traditional tradeoff between generalizability and specificity. The project is structured in two phases, with Phase 2 spanning from month 10 to month 42, featuring critical milestones such as the purification of DARPA-directed proteins within a one-week timeline and the development of a transition and commercialization plan. Proposals are evaluated primarily on overall scientific and technical merit, potential contribution to the national security technology base, and the realism of the budget and schedule. Submissions must be made via the Broad Agency Announcement Tool, with abstracts due by December 4, 2026, and full proposals due by January 22, 2027. Required documentation includes technical and management volumes, a price volume, and a maximum of 20 oral presentation slides. Compliance requirements include adherence to FAR 9.5 regarding organizational conflicts of interest, DFARS 252.204-7012 for safeguarding covered defense information, and CMMC Level 1 or 2 self-certification. Financial administration is handled through the Wide Area Workflow system using a 2-in-1 invoice format, with payments processed by the Defense Agency Financial Services office.
Defense Advanced Research Projects Agcy

POSTED

about 19 hours ago

DEADLINE

in 2 months
View Details
NAICS: 541715
New
Grant
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)
Solicitation # RFA-MH-27-150
The National Institutes of Health is seeking applications to establish the Rapid-Acting Psychotropic Interventional Drugs Clinical Trials Network (RAPIDs-CTN) under solicitation RFA-MH-27-150. The program aims to generate real-world evidence on the safe and effective implementation of rapid-acting psychotropic drugs in routine clinical practice, specifically for high-need populations such as those with treatment-resistant conditions or acute suicide risk. The project utilizes a milestone-driven UM1 Cooperative Agreement mechanism with a total program funding of 12 million dollars and an expected three awards. The network will be structured around a centralized Data Coordinating Center (DCC) and Federated Clinical Sites (FCS) located in diverse settings, including community mental health centers, VA medical centers, and emergency departments. The project is divided into two operational stages: Stage 1 (Years 1–2) focuses on network establishment, site onboarding, and pilot studies to determine safety, feasibility, and costs. Stage 2 (Years 3–5) involves the full-scale execution of unified pragmatic trials. Key requirements include the use of NIMH-supported Common Data Elements for data harmonization and the establishment of automated pipelines for data deposition into the NIMH Data Archive. Applicants must provide letters of collaboration for clinical site commitments and adhere to strict cybersecurity guidelines. Evaluation is based on scientific merit, study design, ethical considerations, and the ability of the DCC to manage multi-site governance and safety monitoring. Applications must be submitted by June 10, 2027, and require active SAM and eRA Commons registrations.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in 7 months
View Details